BRAF and neoplasm: Additional factors include tumor size, histological type, presence of metastases, and incomplete tumor resection.4, 5 Besides clinical and pathological factors, genetic alterations have also been evaluated in PTC, the most important molecular variant is the BRAF p.V600E mutation.6